CB EXPO

19-21 September 2024, Dortmund, Germany

and benefit from discounts at all CB and Partner Events!

CB Expo

Cannabis Business Expo and Conference

La Cannabis Business Expo et Conférence dédiée à l’industrie chanvrière – de la culture à la commercialisation. Présentez votre entreprise, vos produits et votre marque ainsi que vos prestations de service sur un stand ou en tant que sponsor, ou visitez la CB Expo en tant que visiteur professionnel pour développer vos contacts commerciaux dans une très agréable ambiance.

jours

heures

minutes

secondes

CB Expo Dortmund, du 19 au 21 septembre 2024

Du 19 au 21 septembre 2024, à Dortmund, à l’occasion de l’InterTabac, la plus grande foire mondiale des produits du tabac et des accessoires pour fumeurs, se tiendra la prochaine édition du CB Expo – Cannabis Business Expo and Conference. Dans la zone CB Expo, des entreprises leaders et des nouveaux venus passionnants présenteront leurs marques, produits et services. Autour du CB Expo, divers événements annexes offriront un espace pour des discussions privées et un excellent réseautage. Sur les scènes de la CB Conference, des conférenciers de haut niveau discuteront des sujets d’actualité et partageront leur expertise lors de masterclasses. Les principaux points d’intérêt du CB Expo 2024 sont la légalisation anticipée du cannabis à des fins récréatives en Allemagne et dans d’autres pays européens, la promotion du chanvre en tant que matière première, ainsi que les défis et les tendances du cannabis en médecine. L’objectif du CB Expo est d’établir une industrie européenne du cannabis durable pour les générations futures.

Chiffres InterTabac + InterSupply + CB Expo:
Nombre d’exposants : + 700
Nombre de visiteurs : + 14 000

Lieu:
Messe Dortmund

Horaires:
CB Expo (et InterTabac + InterSupply):
Jeudi 19 septembre, de 10h00 à 18h00
Vendredi 20 septembre, de 10h00 à 18h00
Samedi 21 septembre, de 10h00 à 17h00

CB Conference:
Jeudi 19 septembre, de 10h00 à 18h00
Vendredi 20 septembre, de 10h00 à 18h00

CB One – Dîner exclusif Burger & Networking:
Jeudi 19 septembre, 19.00 – 22.00 heures
> Complet – plus de places disponibles

CB Reception:
Vendredi 20 septembre, de 19h00 à 00h00

CB Afterparty:
Samedi 21 septembre, à partir de 22h00

Billets:
La CB Reception et la CB Conference sont accessibles avec le billet VIP CB Expo, disponible pour des jours individuels ou tous les jours.
> Achetez votre billet ici

Restauration et boissons:
La nourriture et les boissons lors de la CB Reception sont incluses dans le prix de tous les billets VIP CB Expo.

Hotels:
Réservez dès maintenant votre hôtel
> Demande d’hôtel

Inscrivez-vous à CB Expo Dortmund, du 19 au 21 septembre 2024

La CB Expo et la Conférence se tiennent en tant qu’événements parallèles, simultanément et sur le même site que l’InterTabac. L’accès à la CB Expo est inclus dans le prix du billet pour les 14 000 visiteurs professionnels d’InterTabac. Inversement, l’InterTabac est accessible à tous les exposants et visiteurs de la CB Expo.

Réservez dès maintenant l’un des stands exclusifs, avec ou sans pack de sponsoring.

CB Company et Messe Dortmund se réjouissent de vous entendre.

> Contact Messe Dortmund
> Contact CB Company

> Download Hallenplan
> Download CB Expo Information

> Tickets

Plan des halls CB Expo Dortmund, du 19 au 21 septembre 2024

La CB Expo et la CB Conference se tiendront désormais au cœur de l’InterTabac. La CB Expo sera accessible à tous les 14 000 visiteurs professionnels de l’InterTabac.

Plan du site CB Expo 2024

> Download plan des halls

Exposants CB Expo Dortmund, du 19 au 21 septembre 2024

Firma / Company	Stand #	Web
A-Sense	CB.C10	www.a-sense.pl
Anhui Sunnybay	CB.C16	www.sunnybay.en.alibaba.com
Anlerr Technology	CB.A04	www.anlerr.com
Barney´s Farm	CB.B02	www.barneysfarm.nl
Boveda	CB.C02	www.bovedainc.com
BrainsBio	CB.B10	www.brainsbioceutical.com
Canna B2B / Canatura	CB.B08	www.cantaturawholesale.com
CannaTrade	(kein/no/pas de Stand)	www.cannatrade.ch
Cannavigia	CB.A08	www.cannavigia.com
CannBro	CB.B20	www.cannbro.com
Cilicon/ ALD Group	CB.B06	www.ciliconplus.com
Cultivators	(kein/no/pas de Stand)	www.cultivators.nl
Emerald Green	CB.A10	www.emeraldgreentech.com
ESA-Test	CB.A14	www.esa-test.de
EVO	(kein/no/pas de Stand)	www.evo-nxt.com
Fluence	(kein/no/pas de Stand)	www.fluence-led.com
Folds Inc	CB.B27	www.foldsrollingpaper.com
GrowerIQ	CB.C06	www.groweriq.ca
HBI Europe	(kein/no/pas de Stand)	www.hbieu.com
INCBA	(kein/no/pas de Stand)	europe.incba.org/#cbexpo2024
Indica Online	CB.C04	www.indicaonline.com
Lumino	(kein/no/pas de Stand)	www.luminorecruit.com
Mr. Terpeenes	CB.B24	www.terpeenes.com
Mr. Tipp´s	CB.B16	www.mrtipps.com
MyCrops	CB.B26	www.mycrops.ag
OCB	(kein/no/pas de Stand)	www.ocb.net
Pipp Horticulture	(kein/no/pas de Stand)	www.pipphorticulture.com
Royal Queen Seeds	CB.A16	www.royalqueenseeds.com
Saxonia Diagnostics	CB.A14	www.saxonia-diagnostics.de
Seed Stockers	CB.A12	www.seedstockers.com
Sensi Seeds	(kein/no/pas de Stand)	www.sensiseeds.com
Storz&Bickel	CB.C08	www.storz-bickel.com
SynBiotic SE	CB.A02	www.synbiotic.com
Therakann	(kein/no/pas de Stand)	www.therakann.com
TM Nature Distribution	CB.B14	www.naturetechnologie.com
TRE House	CB.B18	www.trehouse.com
TSRgrow	CB.A06	www.tsrgrow.com
VertiFarm	(kein/no/pas de Stand)	www.vertifarm.de
Wenzhou Good Job	CB.C12	www.goodjob3.com

Billets CB Expo Dortmund, du 19 au 21 septembre 2024

La CB Expo est accessible avec un billet d’entrée InterTabac régulier – et inversement : avec le billet CB Expo, vous pouvez visiter gratuitement les halls de l’InterTabac.

Avec le billet CB Conference, vous avez également accès aux deux scènes de conférence (Main Stage et Deep Dive Stage) ainsi qu’à INCBA-Europe. Le café et l’eau minérale sont inclus dans le prix, et le billet est disponible pour un ou les deux jours de la conférence.

Le billet VIP comprend l’accès à la CB Expo et à la CB Conference, ainsi que la CB Reception le vendredi soir. La CB Reception promet une soirée inoubliable : de délicieux plats et boissons associés à des rythmes entraînants dans une atmosphère agréable offrent des conditions optimales pour un excellent réseautage et une fin agréable à la conférence de deux jours.

Programme CB Expo Dortmund, du 19 au 21 septembre 2024

La CB Conference se distingue par son programme complet sur trois scènes avec des intervenants de renom du monde entier. Les thèmes principaux de la CB Expo 2024 sont la légalisation attendue du cannabis récréatif en Allemagne et dans d’autres pays européens, la promotion du chanvre en tant que matière première, et les défis et tendances du cannabis en médecine.

Highlight: INCBA Europe @ CB Expo

Second Cannabis Law Conference In Europe

Après 2022 à Zurich, l’International Cannabis Bar Association Europe (INCBA Europe) organise à nouveau une conférence sur le droit européen du cannabis, en collaboration avec la CB Expo à Dortmund. Jusqu’à 20 éminents avocats de ce domaine en Europe sont attendus pour présenter et discuter des évolutions actuelles. En raison du contexte réglementaire, des marchés entiers se sont effondrés, mais en même temps, de nouvelles opportunités et possibilités émergent dans un environnement qui se libéralise en Europe. La conférence examinera ces opportunités et défis sous un angle juridique. Le public cible comprend non seulement d’autres avocats, mais aussi d’autres acteurs progressistes de l’industrie du cannabis, qui peuvent utiliser les présentations comme ressources pour leur propre travail.

europe.incba.org

Retrouve ici le programme complet de la CB Conference 2024 :

CB Expo Dortmund 2024

Thursday, 19th September 2024

10.30 - 10.45
CB Expo Welcome [MAIN STAGE]
Language: German / Simultantranslation: English
Intervenants : Ben Arn, Sabine Loos

10.45 - 11.05
Key note 1: Sectors for Industrial Hemp, Medical, and Recreational Cannabis – Market Insights, History, and Outlook [MAIN STAGE]
"The recent changes in German cannabis legislation will have significant positive effects on the sectors of industrial hemp, medical cannabis, and recreational cannabis." – Daniel Kruse 2024. In his keynote speech, Daniel Kruse will discuss the latest developments in the hemp and cannabis market and present current market data. Furthermore, he will take you on a brief journey through the history of cannabis legalization and explain the pillars of German cannabis law and its potential positive impacts on the areas of industrial hemp, medical cannabis, and recreational cannabis. Language: English / Simultantranslation: German
Intervenants : Daniel Kruse

11.15 - 12.15
Panel 1: A first review – how did the German Cannabis landscape change in the last six months [MAIN STAGE]
1st April marks a fundamental change for the everything related to cannabis in Germany. With the de-scheduling and de-criminilisation of Cannabis this has been a huge success for activists fighting for decades. But what is the impact six month later? How did patients and consumer benefit? And what’s the impact on the cannabis industry – no matter if its medical, consumer or hemp. It’s time for a first review. Language: German / Simultantranslation: English
Intervenants : Benedikt Sons, Daniel Kruse, Dirk Heitepriem [Moderator], Georg Wurth, Olivia Ewenike, Sven-Roger von Schilling

12.30 - 13.30
Panel 2: Model Projects – Are They the Path to Pan-European Legalization? [MAIN STAGE]
This panel will explore the current state of cannabis trials in Switzerland, the Netherlands, and Germany. Experts will discuss the motivations behind these trials, their objectives, and public health and safety measures. They will also address legal and regulatory adjustments, economic impacts, and social implications. Key topics include Switzerland’s pilot projects, the Netherlands’ "weed experiment," and Germany’s preparations for recreational cannabis. Join us for an in-depth analysis of how these trials are influencing cannabis policy in Europe. Language: English / Simultantranslation: German
Intervenants : Adele Hollmann, Alfredo Pascual [Moderator], Luca Cereghetti, Peter Homberg, Simone van Breda, Timo Bongartz

12.45 - 13.00
Opening Address [INCBA STAGE]
After 2022 in Zurich, the International Cannabis Bar Association Europe (INCBA Europe), in cooperation with CB Expo, will again organize a conference on European cannabis law in September 2024 in Dortmund. Up to 20 top lawyers in this field from all over Europe are expected to present and discuss the latest developments. Due to the regulatory environment, entire markets have collapsed, but new opportunities and possibilities are also emerging in a liberalizing environment in Europe. The conference will deliberate these opportunities and challenges from a legal perspective. The target audience is not only other lawyers, but also sophisticated business professionals in the Cannabis industry, who can use the presentations as a resource for their own work. Language: English
Intervenants : Daniel Haymann, Kai-Friedrich Niermann, Marie Sanchez, Robert Jappie

12.45 - 13.45
The Growing Sessions - Session 1: Unveiling the Future: Breakthroughs in Cannabis Genetics [DEEP DIVE STAGE]
Explore groundbreaking advancements in understanding and manipulating cannabis genetics. Topics will include the development of novel cultivatars with targeted cannabinoid and terpene profiles, the role of genetic research in enhancing yield and resistance to pests and diseases and the search for F1 hybrid genetics. Language: English
Intervenants : Atiyyah Ferouz, Dara Kearney, Gavin George, Max Majot, Sonny Moerenhout [Moderator]

13.00 - 14.00
Track 1: Single Convention vs. Free Markets and Free Movements of Goods – which regime will prevail when it comes to medical cannabis distribution in the EU and globally? [INCBA STAGE]
In November 2023, the German government decided to lift all restrictions on the cultivation of medicinal cannabis in Germany. Since April 1 the three already licensed growers of medical cannabis in Germany will be able to produce cannabis without quantity and product restrictions, as well as any other company that can grow cannabis to pharmaceutical standards. The panel will discuss what consequences this decision will have for the national and international markets, as Cannabis has a special status as an international commodity. Different legal regimes like the Single Convention from 1961 and resulting import bans for medical cannabis, the fundamental freedoms of the EU, and numerous domestic regulations are causing a mess and make it impossible to give clear and comprehensible guidance to the industry. The panel will discuss the state of affairs and future developments for medical cannabis in the EU and globally. Language: English
Intervenants : Andrés Lopez, Constantin von der Groeben, Jason Moscovici, Kai-Friedrich Niermann [Moderator], Robert Hoban

13.45 - 14.05
Key note 2: Exploring Germany‘s Cannabis Industry - Insights, Opportunities and Success Strategies [MAIN STAGE]
In this Keynote, Jürgen Bickel will review key milestones in the global cannabis industry, highlighting important lessons learned from various markets. He will then focus on the specific context of cannabis legalization in Germany, providing an outlook on future developments and opportunities. The session will also outline effective strategies for business success in the German market, offering insights into navigating the evolving landscape and capitalizing on emerging trends. Language: German/ Simultantranslation: English
Intervenants : Jürgen Bickel

14.15 - 15.15
The Growing Sessions - Session 2: Cutting-Edge Advances in Cannabis Cultivation Research [DEEP DIVE STAGE]
Leaders in cannabis research will delve into the latest developments in cultivation research. You can expect a comprehensive overview of advancements that are shaping the future of cannabis cultivation. Language: English
Intervenants : Céline Nicole-deGroot, Christian Büser, Dominique van Gruisen, Kjell Sneeuw, Sonny Moerenhout [Moderator]

14.30 - 15.30
Panel 3: The Tension Field of Cannabis Clubs: Expectations, Challenges, Solutions [MAIN STAGE]
Cannabis clubs, particularly their boards, face a multitude of expectations. The public, authorities, and not least their own members, place high demands on them. How can these tasks be understood and addressed? Speakers from science, law, cannabis club businesses, and club founders provide insights. Language: German / Simultantranslation: English
Intervenants : Henry Wieker [Moderator], Jörg Meyer-Brenken, Lorenz Minks, Marcus Geschwandtner, Stefan Röhrl, Stefanie Arndt

14.30 - 15.30
Track 2: All over the place: The journey to GMP compliance [INCBA STAGE]
Join us for an in-depth discussion on the legal nature of Good Manufacturing Practice (GMP) standards and the intricacies and complexities of achieving this coveted certification. We are honored to feature the President of the Association of the Swiss Cannabis Industry (IG Hanf), who also serves as a consultant to cannabis companies navigating the rigorous GMP certification process through his role as co-founder of a successful start-up. Our distinguished panel includes representatives from a company that recently achieved GMP certification in a record time of less than 1.5 years, offering valuable insights into their successful journey and practical advice on the do's and don'ts of the process. Additionally, we will hear from the market leader in the medical cannabis sector in Switzerland, sharing extensive experience and best practices in operating under GMP conditions. We are also joined by an expert from the United States who will provide a perspective on the evolving quality standards for cannabis in North America, covering both medical and non-medical sectors. Don't miss this opportunity to gain valuable insights from industry leaders on the challenges, successes, and future trends in GMP compliance. Language: English
Intervenants : Daniel Gelemanovic, Daniel Haymann [Moderator], Jana Weltzin, Peter Homberg, Peter Steger, Timo Bongartz

15.45 - 16.05
Key note 3: The Potential of Cannabis: Stuck in between Subculture and Mainstream [MAIN STAGE]
The challenges surrounding cannabis are manifold: from the lack of EU-wide harmonization and fragmented cross-border regulations, to the sluggish development of category-specific identity standards, and category bending to ensure the marketability of individual product groups. This also involves seeking answers to the challenges of specific categories and their corresponding regulations. How can individual commodities and consumer goods be commercialized to tap into the full economic potential of cannabis? Which cannabis products are stuck between subculture, niche, and mainstream markets? What role does harmonization towards existing categories play, even under facilitated conditions similar to those in France or the UK? What is the smallest common denominator that allows cannabis, in all its diversity, to rise from a niche topic to a significant economic factor for Europe? Language: German / Simultantranslation: English
Intervenants : Lisa Katharina Haag

15.45 - 16.45
The Growing Sessions - Session 3: Innovative Design Concepts for Cultivation Club Facilities [DEEP DIVE STAGE]
Discussing creative approaches to designing cannabis cultivation spaces within social club environments. Focus on integrating efficient cultivation systems with inviting and functional growing spaces, addressing regulatory challenges unique to social club settings, that promotes successful cultivation practices. Language: English
Intervenants : Franz Josef Sima, Marc Montandon, Martijn Vernnoij, Mikhail Sagal, Sonny Moerenhout [Moderator]

16.00 - 17.00
Track 3: Medical Cannabis in Ukraine and Israel – two keynotes from two special jurisdictions [INCBA STAGE]
Medical cannabis has been established in Israel for decades. The research for medical cannabis in Israel is even older, and world-leading. Cannabis is used in a variety of medical applications, including in nursing homes and the military. The legal framework for medical cannabis in Ukraine will be liberalized in the summer of 2024. What the market will look like and how it will develop is still difficult to predict at present. In this panel, we will hear two keynote speeches by Hannah Hlushchenko and Adi Rozenfeld about the history of medical cannabis in both countries, the current legal status, the next developments, and what Ukraine can learn from Israel in the further process of establishing medical cannabis. Followed by a discussion. Language: English
Intervenants : Adi Rozenfeld, Borys Danevych [Moderator], Hanna Hlushchenko

16.30 - 17.30
Panel 4: Germany's Cannabis Regulation: of shattered Dreams, Real Opportunity and Revised Plans [MAIN STAGE]
Germany's cannabis regulation is at the center of intense debates. Critics are voicing their discontent loudly, while proponents suffer from the slow progress. Although the original goal of specialized shops has not been realized and some earlier hopes for quick changes have been dashed, real opportunities for a legal and regulated cannabis market are still emerging. However, the path forward requires adjustments and new strategies to successfully implement the revised plans. Experts from the field are discussing on this panel, how the situation is playing out in reality and everyday cannabusiness life. Language: German / Simultantranslation: English
Intervenants : Leon J. Braun, Lisa Katharina Haag [Moderator], Niels Lutzhöft, Nikita Cretu, Thomas Hauk, Vanessa Kulik

Friday, 20th September 2024

10.30 - 10.50
Key note 4: The Current State of the US Cannabis Market [MAIN STAGE]
2024 could be the turning point for cannabis reform in the United States. As a leader on all aspects of cannabis reform, David Culver will speak about the US Presidential race, the impacts of the rescheduling of cannabis, reform efforts on Capitol Hill, and state level initiatives. Culver will focus on the impacts of these changes both at home and abroad. Language: English / Simultantranslation: German
Intervenants : David A. Culver

10.30 - 11.30
The Growing Sessions - Session 4: High-Tech Horticulture: Advancements in Cannabis Cultivation Technology [DEEP DIVE STAGE]
Discussing the latest technological innovations transforming cannabis cultivation. Topics will include the integration of AI and automation in cultivation processes, advancements in lighting technologies such as LEDs and more. Language: English
Intervenants : Ben Niehaus, Rob Perry, Sonny Moerenhout [Moderator], Torsten Schober

10.30 - 11.30
Track 4: Marketing and Advertising in the Cannabis Sector [INCBA STAGE]
Marketing and Advertising in the North American cannabis industry is well established. As the European market grows, both in medical and adult-use/recreational sectors, this panel will consider what lessons can be learned from the US & Canada, what marketing endeavours have already been successful in Europe, and what are the risks involved in engaging in aggressive promotional activities. Jon Robson will speak on the challenges of implementing a controversial but effective marketing strategy on behalf of Mamedica in the UK. Josh Normanton will provide legal expertise, advising on the risk of regulatory intervention in respect of marketing activities. Language: English
Intervenants : Aleksandra Vujinović, Jon Robson, Josh Normanton, Nick Kenny, Robert Jappie [Moderator]

11.00 - 12.00
Panel 5: Social and Cultural Contrasts between North America and Europe [MAIN STAGE]
Join this panel to explore the cultural and social contrasts between Europe and North America and how they directly and indirectly impact the marketing, sales and market entry processes for cannabis companies globally. Language: English / Simultantranslation: German
Intervenants : David A. Culver, Farida Hussain [Moderator], Jillian Reddish, Kate Holste, Michael Sassano, Michael Steinmetz

11.45 - 12.45
The Post Harvest Session - Session 1: Cannabis 2.0: Innovations in European Cannabis Extraction [DEEP DIVE STAGE]
This panel will explore the cannabis extraction landscape across medical, wellness, and recreational markets in Europe. Experts will discuss demand trends among patients, consumers and doctors for extract-based products such as oils, capsules, and vapes compared to flower, and the impact of regulatory frameworks on the availability of these products. Attendees will gain unique insight into advancements in extraction techniques, R&D and product formulations, quality assurance, and what to look for when searching for an extraction partner or equipment provider. Language: English
Intervenants : Alexander Rieg, Alisia Ratliff, Lily Temperton [Moderator], Rui Soares

12.00 - 13.00
Track 5: Semi-Synthetical Cannabinoids – where to go from here? [INCBA STAGE]
Over the past few years, many new psychoactive substances have emerged on the global and European markets. Among those substances, many are semi-synthetic cannabinoids such as HHC, THCP, H4-CBD. While most European countries are taking a prohibitive approach by classifying any new psychoactive substance as a narcotic substance, Czech Republic seems to be taking a less restrictive route with the Act on Psychomodulatory Substances that is expected to enter into application in 2025. This panel will discuss the current status of semi-synthetic cannabinoids, the effects and consequences of the prohibitive approach on the European market and explore different paths that could lead to a safer market for both consumers and business operators. Language: English
Intervenants : Amber Lengacher, Kai-Friedrich Niermann, Marie Sanchez [Moderator], Vojtěch Sucharda

12.15 - 12.45
Key note 5: From Weed to Seed with Future Potential: The Role of Hemp in Climate and Social Justice [MAIN STAGE]
Drawing on research from my book "H is for HEMP" (published in March 2022) and my ongoing research on the global hemp industry, this keynote will highlight the urgent need to reframe cannabis and hemp within a context of regulated, sustainable use. By harnessing the full potential of hemp, we can pave the way for climate-resilient development and social justice, transforming "weed" into a seed of hope for the future. The keynote will focus on ecological building and rebuilding in Morocco and Ukraine. Language: English / Simultantranslation: German
Intervenants : Maren Krings

13.00 - 14.00
Panel 6: Emerging Voices in Cannabis: Recent Entrants, their Motivations and Focus Areas [MAIN STAGE]
Explore the dynamic and evolving landscape of the cannabis industry as we spotlight the newest voices making waves in this space. This panel will delve into the motivations driving recent entrants — from alcohol, to tobacco and pharmaceutical companies. Attendees will gain insights into who these newcomers are, the unique perspectives and expertise they bring to the cannabis industry, and how they are shaping the future of cannabis through innovation, disruption, and a commitment to safety and responsibility. Language: English / Simultantranslation: German
Intervenants : Chris Murray, Deepak Anand [Moderator], Nick Kenny, Omar Khan, William Muecke

13.00 - 14.00
The Medical Sessions - Session 1: Medical cannabis cultivation in Germany: domestic home cultivation or imports - which is the better option? [DEEP DIVE STAGE]
Existing cannabis growers in Germany have recently extended their licenses to be able to grow even more cannabis domestically. Is growing in Germany a good strategy economically or could importing make more sense? *How does this affect the quality differences of the products? In this panel, we compare growing medical cannabis domestically for the German market with importing it from other countries around the world. Language: English
Intervenants : Bijan Christoph Hezarkhani [Moderator], Marcel Riggs, Philipp Goebel, Šárka Betke, Sascha Mielcarek, Thomas Ahlberg

13.30 - 14.30
Track 6: New Developments in North America: Updates on Canada and the US [INCBA STAGE]
In the past two years, updates touching cannabis legalization in North America have sparked many conversations between cannabis professionals in North America. Canada has just completed its mandated review of the Cannabis Act, the piece of legislation at the center of legalization in Canada, and the resulting report has raised many eyebrows. On the US side, discussions surrounding rescheduling have renewed an interest in cannabis-derived therapeutic products and their development. It is therefore an exciting time to take another look at the status of cannabis in the US and Canada and to study how things have been evolving. What were the conclusions of Canada’s legislative review? In the US, what new regulatory hurdles will stakeholders have to face on both local and international markets? How has the regulatory framework for cannabis changed in North America and what foreseeable updates are coming down the pipeline? Join us for a presentation of the updates and challenges that have emerged in North America and how they are being addressed by industry and legal professionals alike. This session is for anyone looking to understand for an update of the framework for regulated cannabis in the US and Canada, as well as anyone looking to discuss the commercial opportunities that these legal changes provide. Language: English
Intervenants : Jana Weltzin, Jason Moscovici [Moderator], Shane Pennington

14.15 - 14.45
Key note 6: Grass Is Greener: The Cannabis market’s evolution, challenges, and state of play [MAIN STAGE]
As the global cannabis industry navigates volatility to reach a state of pragmatic optimism, conscious of false dawns and corporate underperformance but encouraged by increasing normalisation and the international spread of legalisation, this keynote will assess the current state and future prospects for the world cannabis market. Leveraging proprietary data and proven thought leadership to surface the key consumer and industry trends and international size of opportunity, the session will be indispensable in plotting a path for an industry moving from niche taboo into the mainstream. Language: English / Simultantranslation: German
Intervenants : Spiros Malandrakis

14.15 - 15.15
The Medical Sessions - Session 2: Market authorised cannabis-based medicines: pipe dream or not too distant reality? [DEEP DIVE STAGE]
The number of market authorised cannabis-based medicines continues to remain low compared to the number of products available in the market, a number that seems to be increasing almost daily. How important is it to see more market authorised medicines? In this panel we discuss the need, or lack thereof, for market authorized cannabis-based medicines and their impact. Language: English
Intervenants : Andrés Lopez, Bijan Christoph Hezarkhani [Moderator], Bill Purves, Ilias Manolopoulos, Nadine Herwig, Nicole Besse

15.00 - 16.00
Panel 7: Emerging Trends in Cannabis: Next-Generation Products and Methods [MAIN STAGE]
This panel will explore the latest innovations in product formats and delivery methods within the cannabis sector. As medical cannabis evolves across Europe, there's a noticeable shift from traditional flower products to extracts. However, identifying the right devices and delivery methods remains challenging. In the realm of consumer wellness, there's a growing interest in new ways to consume CBD. This panel will discuss the regulatory and market implications of developing and launching these innovative products, offering insights into the future of cannabis consumption. Language: English / Simultantranslation: German
Intervenants : Aron Byrne-Carter, Georgia Glick [Moderator], Hari Guliani, Jürgen Bickel, Tim Matthews

15.00 - 16.15
Track 7: International Panel – Legal challenges in dynamic cannabis jurisdictions [INCBA STAGE]
This panel will shed light on the most pressing legal challenges in a wide variety of jurisdictions, including Panama, Colombia, Spain, Italy and Germany. Panama is on the verge of introducing a comprehensive medical cannabis program, Colombia is still fighting legacy related stigmatization, Spain’s cannabis framework is confusing and legislators are dragging their feet on a medical cannabis legalization. Italy stuns the world with expanding restrictions and a near irrational vendetta on CBD products, and Germany is emerging as a bright, innovative star in the European cannabis markets. Our speakers will explore the main challenges in their jurisdictions, followed by an engaging conversation. Language: English
Intervenants : Giacomo Bulleri, Guillermo Fernández Navarro, Ohad Kiperstok [Moderator], Ricardo Omar Almanza, Susanne Pech

15.30 - 16.30
The Medical Sessions - Session 3: Medical Cannabis Flowers: here to stay or too risky for most physicians? [DEEP DIVE STAGE]
Private prescriptions of cannabis flower have seen a sharp increase in Germany since April 1st, how long will this trend continue? What effect will the recent amendments by the G-BA have on this trend? Is it really easier to get a prescription or is there more pressure on physicians? In this panel we take a closer look at the current state of market and where things might be headed. Language: German
Intervenants : Armin Prasch, Bijan Christoph Hezarkhani [Moderator], Carsten Elfering, Thorsten Tuschy

16.15 - 17.15
Panel 8: Wrap up of the INCBA Europe and CB Expo [MAIN STAGE]
For two days, the CB Expo's three stages—the Main Stage, the Deep Dive Stage, and the INCBA Stage—hosted presentations, discussions, and commentary on the current issues affecting the cannabis industry. At the end, selected speakers from all three stages will come together for the final panel. Where do we stand, and where do we want to go to build a sustainable European cannabis industry? Language: English / Simultantranslation: German
Intervenants : Adi Rozenfeld, Alfredo Pascual, Daniel Haymann [Moderator], Farida Hussain, Hanna Hlushchenko

Ben Arn

CEO of CB Company

Ben has been the organizer of Cannabis Events in Switzerland since 2006. His projects are the CannaTrade - International Hemp Fair + Festival (B2C and B2B), the CB Expo - Cannabis Business Expo and Conference (B2B) and the CB Club - Cannabis Business Network event (B2B). In 2022 he also organized the Cannabinoid Conference 2022 (12th IACM Conference and 1st SSCM Conference) in Basel. His passion is organizing events and connection people, and for sure too: The cannabis plant and his enormous potential.

Sabine Loos

Chief Executive at Westfalenhallen Unternehmensgruppe

Sabine Loos has been Chief Executive Officer of the Westfalenhallen Unternehmensgruppe GmbH since 2011. She manages the business of the group of companies (Messe Dortmund, Kongress Dortmund and Westfalenhalle) with around 60 trade fair dates each year, 1,100 congress events and 144 events in the Westfalenhalle.

Daniel Kruse

CEO of Synbiotic SE, President of EIHA

Daniel Kruse – a German hemp pioneer with around 30 years of experience in the hemp and cannabis sector and a successful founder of several companies. As CEO of SYNBIOTIC SE, a leading European hemp and cannabis group, and President of the European Industrial Hemp Association (EIHA), Kruse is a key advocate for the destigmatization of hemp.

Benedikt Sons

Co-Founder & CEO of Cansativa Group

Benedikt is a pioneer in building new businesses and in taking them to scale. Since founding in 2017, Cansativa has become the leading platform for cannabis in Germany: As such Cansativa developed into the leading “One-Stop Shop” with a unique and the most comprehensive multi-brand portfolio in the German market.

Dirk Heitepriem [Moderator]

President of BvCW, Vice President External Affairs at Aurora Europe GmbH

Dirk is representing the German cannabis industry as the president of the Cannabis Industry Association and is currently VP External Affairs of Aurora Europe. He is working in the Cannabis sector since 2018 with 20 years of experience in government relations in Europe.

Georg Wurth

CEO of German Cannabis Association (DHV)

Georg is leading europes biggest legalize ngo since more than 20 years. He is an outstandig expert in german and international cannabis politics.

Olivia Ewenike

Attorney at Law at Ewenike Law Firm, Founding Partner of Lito Law Academy GmbH

Olivia Ewenike is an attorney specializing in cannabis law, dedicated to helping companies establish themselves in the German cannabis market. As a Cannabis Business Development Advisor, she provides comprehensive consulting services for businesses in this sector. Olivia is also the Founding Partner of Lito Law Academy GmbH, where she teaches about the establishment and operation of cannabis clubs.

Sven-Roger von Schilling

CFO of Grünhorn, Managing Director of the Schurer Pharma & Kosmetik GmbH

Sven-Roger von Schilling has over 20 years of international leadership in healthcare, renewables, and IT services. As a seasoned company builder and CFO, he excels in scaling companies and positioning them for sustainable growth. He has successfully IPO-ed three companies on the Frankfurt Stock Exchange and advised on numerous IPO and SPAC projects. He holds an MBA from the J.L. Kellogg School of Management.

Adele Hollmann

Business Development & Education Manager - Adult-Use, Sanity Group GmbH - Grashaus Projects

Adele Hollmann is Business Development & Education Manager - Adult-Use at the Sanity Group and a certified cannabis sommelier. Together with the "Grashaus Projects" team, she initiated a Swiss pilot project for recreational cannabis and opened the first legal dispensary in Europe. Her responsibilities include the application process, budtender training and quality management. She previously studied agricultural and horticultural sciences and specialized in cannabis.

Alfredo Pascual [Moderator]

Director of Investment Research at Seed Innovations Ltd (LON:SEED)

Based in Germany, Alfredo Pascual, CFA, is Director of Investment Research at SEED Innovations, a London’s AIM-quoted company known for its investments and successful exits in the European medical cannabis space. As a highly specialized cannabis industry analyst, Alfredo has established himself as a trusted authority in the field. Before joining SEED, he worked as international analyst for MJBizDaily, a leading business news and analysis resource for the cannabis industry.

Luca Cereghetti

COO of Pure Holding AG

Luca Cereghetti is the Chief Operating Officer of Pure Holding AG. He began working at the company in 2020 as an intern between his bachelor's degree in Business Administration and his master's degree in Accounting & Finance. After a rapid rise within the company over the past few years, he now serves as COO, overseeing the company's operations and strategic initiatives.

Peter Homberg

Partner & Head of European Cannabis Group Dentons Europe (Germany) GmbH & Co. KG

Peter Homberg focuses on life sciences, IP, corporate law and M&A transactions in the life sciences and high-tech sector as well as in R&D and cooperation agreements. He has extensive experience providing legal advice on compliance issues and is the head of the European Cannabis sector group.

Simone van Breda

Chairman at Bond van cannabis detaillisten (Union coffeeshop retailers)

Simone is the chairman of the Union of coffeeshop retailers in the Netherlands, working at the national and international level to advance regulation of cannabis and to professionalize the emerging industry. She is one of the key figures who advocates on the legalization on a European level.

Timo Bongartz

CEO at Cannavigia

Timo is an experienced business innovator with over 15 years of experience in digital, horticulture, and cannabis industries. As the CEO at Cannavigia, he promotes sustainable growth through software and consulting solutions. With an MBA from the University of Applied Sciences in Munich and a focus on sustainability, Timo is shaping the future of these sectors.

Daniel Haymann

Legal Counsel at MME Legal | Tax | Compliance

Daniel Haymann specializes in corporate and commercial law, focusing on investments, venture capital, financing, and regulatory issues in healthcare and consumer goods. He advises on THC, CBD, GMP, GDP, and food regulations. Co-founder and co-chair of INCBA Europe, he leverages his Swiss-Israeli dual citizenship and prior experience as a commodity trader to serve clients globally.

Kai-Friedrich Niermann

Cannabis Attorney at KFN+ Law Office

Kai is a cannabis industry expert with extensive practice in cannabis and business law. He provides comprehensive legal support, from contract drafting and company formation to day-to-day legal matters, including white-collar criminal law. Author of the blog canna-biz.legal, Kai offers insights into the legal status and developments of cannabis in Germany and Europe. He advises large CBD and medical cannabis companies and associations, including the European Industrial Hemp Association (EIHA). Kai speaks at international cannabis conferences and publishes in law journals. He holds a law degree from the Universities of Marburg, Adelaide, and Cologne.

Marie Sanchez

Lawyer & Founder Nooa Avocats

Marie Sanchez is a lawyer at the Bars of Paris and Quebec. After starting her career in Singapore with a large pharmaceutical group, she worked for nearly 10 years in international law firms before founding NOOA Avocats. She specializes in life sciences regulation, therapeutic cannabis, and well-being hemp. Marie regularly participates in training and conferences globally. She holds a Master II in Health Industry Law from the University of Montpellier I and an ESSEC-Mannheim Executive MBA.

Robert Jappie

Partner at Fieldfisher LLP

I am a Partner in Fieldfisher’s Regulatory Group. I specialise in Life Sciences Regulation for the UK and Europe, providing advice and representation to a range of nascent industries in the Life Sciences sector. I have a particular focus on Cannabis Regulation, Food/Agri-Tech and Healthcare.

Atiyyah Ferouz

CEO of AgCann Consultancy Ltd.

Atiyyah is the founder of AgCann Consultancy, an international consulting firm engaged in operations, quality assurance, and tissue culture services. She is also the Executive Director of the International Cannabis Quality Standards Association, a not-for-profit dedicated to the development of industry best practices and policy advisement

Dara Kearney

Expert in cultivation at Barney's Farm

Dara, a seasoned cultivator formerly with Devils Harvest Seeds, has now brought his expertise to Barney’s Farm Seed Company. Renowned for his innovative techniques and deep understanding of cannabis genetics, Dara continues to push the boundaries of cannabis cultivation, ensuring the highest quality and potency in every strain.

Gavin George

CEO of Puregene

Dr. Gavin George, CEO of Puregene AG, where genomics technologies are applied to cannabis and hemp for stability, performance, and yield. After his postdoctoral research at ETH Zurich, 14 publications and contributions to 3 books, he is aiming to expand the potential of hemp in agriculture.

Max Majot

Technical Manager & Grow Expert at Royal Queen Seeds

Cannabis cultivation expert, who excels in project and infrastructure development. His mastery of grow techniques and site management ensures Royal Queen Seeds (RQS) consistently delivers high-quality, elite products across all markets.

Sonny Moerenhout [Moderator]

Managing Partner at Cultivators

Since 2019, Sonny, a founder of Cultivators, has applied his expertise to the growth of licensed cannabis and hydroponic lettuce businesses. With a background in plant science from Wageningen University and extensive experience in cultivation, consulting, and research, Sonny emphasizes collaboration across pharmaceutical, horticultural, and hobby sectors. Cultivators focuses on innovation, sustainability, and tailored solutions, committed to elevating your business in this dynamic field as a partner in growth.

Andrés Lopez

International Regulatory Affairs Manager at Avextr Pharma GmbH

Andrés is co-author of cannabis regulation and was Director of the Colombian Narcotics Authority. He is a chemist by profession and experienced in Drug Policy, being recently candidate for the International Narcotics Control Board. Andres currently holds the position of Director International Regulatory Affairs for Avextra Pharma.

Constantin von der Groeben

Co-Founder & Managing Director of Demecan

After studying law, Dr. Constantin von der Groeben worked as a lawyer in Berlin and New York, and later at the German Federal Ministry for Economic Affairs and Energy. With the 2017 "Cannabis as Medicine Act," he co-founded DEMECAN with Dr. Cornelius Maurer and Dr. Adrian Fischer. DEMECAN is the only independent German producer of medical cannabis for BfArM. As managing director, von der Groeben oversees legal, regulatory affairs, strategic projects, communications, and HR. DEMECAN aims to provide high-quality medical cannabis in Germany. The company plans to expand into the consumer market, potentially growing from 70 to 250 employees and contributing to regional economic strength.

Jason Moscovici

Founder & President of Provisions Legal Services Inc.

Jason Moscovici is a lawyer, biochemist, and founder of Provisions Legal Services, a Canadian firm specializing in regulated industries. He focuses on intellectual property and regulatory compliance in cannabis, pharmaceuticals, and related sectors. Jason is a trusted legal advisor in the international cannabis industry.

Kai-Friedrich Niermann [Moderator]

Cannabis Attorney at KFN+ Law Office

Robert Hoban

Strategic Advisor at Cannabis Industry Group Clark Hill PLC

Bob Hoban, a pioneer in the cannabis industry since 2008, founded Hoban Law Group (HLG), the first full-service cannabis law firm. HLG operates in 17 states and 10 countries with over 50 specialized attorneys. Bob has shaped cannabis law globally, advised numerous governments, and is a sought-after speaker and media expert. Recognized as a "Cannabis Law Trailblazer," he has been influential in establishing and growing the cannabis and CBD industries.

Jürgen Bickel

Co-Founder & Managing Director of Storz & Bickel GmbH

Jürgen Bickel is the Managing Director and Co-Founder of STORZ & BICKEL GmbH, a renowned manufacturer of premium, medically certified vaporizers. With over 24 years in the industry, STORZ & BICKEL is a pioneer and global leader, reflecting the visionary thinking of its founders. Bickel is a top entrepreneur in the European cannabis industry.

Céline Nicole-deGroot

Senior Researcher at Philips LED Horticulture solutions

Dr. Céline C.S. Nicole-de Groot, a senior researcher at Philips since 2001, specializes in physics, plant sciences, chemistry, and sensing technology. With 15 years of expertise in LED lighting for horticulture, she focuses on improving yield and quality in medicinal cannabis. She leads indoor farming research in the Netherlands and supervises university students at Wageningen University & Research.

Christian Büser

PhD Candidate at the Institute of Crop Science, University of Hohenheim

I finished my Masters degree in Agricultural Sciences in February 2023 and started my PhD in October 2023. The research focuses on the cultivation of medicinal Cannabis in indoor and outdoor cultivation systems using subsurface drip irrigation systems and nanoparticles.

Dominique van Gruisen

CEO of Innexo BV

With over 15 years of experience in the cannabis industry and biotech, Mr. van Gruisen leads Innexo, a contract research testing station for medical cannabis propagation, cultivation and post-harvest processing.

Kjell Sneeuw

Cultivation specialist at Cultivators

Kjell Sneeuw is dedicated to discovering innovative methods of cultivating high-quality medicinal cannabis. Through his studies at Wageningen University and work as Project Manager Cultivation for Compounds he translates and applies cultivation research into practical standards.

Henry Wieker [Moderator]

Coordinator at BCAv

Henry is the founder and managing director of HHH Hemp Harvesting Technology, a cannabis flower harvesting equipment manufacturer. He chairs the Cannabis Social Club Hannover, Cannabis Cultivation Community Hannover 1, and NICA. He also coordinates the Federal Association of Cannabis Cultivation Associations (BCAv). With extensive global cannabis industry experience, Henry is dedicated to international cannabis initiatives networking.

Jörg Meyer-Brenken

Head of Sales at Cannavigia

Jörg is a lighting engineer (Dipl.-Ing.) with nearly 20 years of experience at OSRAM and Fluence. He has extensive international project experience, delivering innovative lighting solutions across sectors. For the past 8 years, he has specialized in horticultural lighting, particularly cannabis cultivation, enhancing plant growth and optimizing yields. He now drives and coordinates global sales at Vigia.

Lorenz Minks

Chief Product Owner of 420cloud, Blogger at Research Garden

Lorenz has covered the German and Swiss cannabis scene as a blogger since 2017. With a background in business informatics and horticultural sciences, he advises cannabis companies on facility planning, financing, quality assurance, and branding. As Product Owner of 420cloud, he designs software solutions for cannabis clubs.

Marcus Geschwandtner

Managing Partner at growUp!consulting, Attorney & Partner at Dr. Fandrich Rechtsanwälte, Bonn

growUp!consulting specializes in health care and management, including consumer and medicinal cannabis, and industrial hemp (www.growupconsulting.de). For legal advice, they closely cooperate with Dr. Fandrich Rechtsanwälte (www.fandrich-rae.de). Dr. Marcus Geschwandtner is sought for strategic concepts and corporate, cooperative, and supervisory law. He is co-editor and author of the upcoming "Cannabis Law (KCanG, MedCanG)" commentary, published by C.H.Beck-Verlag.

Stefan Röhrl

CEO & Co-Founder of Hemp Group Int. GmbH, CSO & Co-Founder of Luxora

Stefan is a key leader in the European cannabis market with 15 years of senior management experience. He owns Cannabis clubs in Spain and businesses in Germany, providing him with a deep understanding of the industry. His strong connections in product development and cultivation are valuable. This background makes him skilled at navigating the complex cannabis market and finding new growth opportunities.

Stefanie Arndt

CEO of Starnabis GmbH

I was the first female Cannabis Social Club founder of 2023 in Germany, I am the managing director of Starnabis GmbH, I have been a recreational user for almost 20 years and a patient for chronic back pain for almost 2 years. I am a living example of how you can stand firmly on your feet with and through cannabis. I work a lot on brain health, physical fitness and the influence of the quality of our thoughts on our health.

Daniel Gelemanovic

CEO, Co-Founder & Jurist MLaw at swisscann tec AG

swisscann Tec, based in Technopark Zurich with a production facility in Glattfelden, is a Swiss cannabis company founded in 2017. We produce and distribute medicinal cannabis products containing THC, focusing on the B2B market in Switzerland and the EU. Our clients include pharmacies, hospitals, pharmaceutical companies, and patients. We hold a Swiss government license for cultivating high-THC medical cannabis.

Daniel Haymann [Moderator]

Legal Counsel at MME Legal | Tax | Compliance

Jana Weltzin

Attorney at JDW, LLC

Jana D. Weltzin, owner of JDW Counsel in Anchorage, Alaska, represents over 250 small to mid-size companies in Alaska and Arizona. Licensed in both states, she specializes in corporate law, start-ups, compliance, land use, and marijuana law. Jana co-chairs the Alaska Governor’s Advisory Task Force on marijuana policy and serves on the board of the International Cannabis Bar Association. Recognized as a 2017 Marijuana Venture Rising Star, she continues to expand her firm through strategic alliances and political relationships. Jana obtained her J.D. from Arizona State University, specializing in Federal Indian Law.

Peter Steger

CEO & Owner of Spagyrik Produktions AG/ Heidak AG, President of IG

Peter Steger is a lawyer and entrepreneur, managing director, and co-owner of Spagyrik Produktions AG, a GMP-compliant pharmaceutical manufacturing company producing herbal medicines, including THC and CBD cannabis tinctures and oils. The company holds all necessary licenses. Peter is also co-owner of HEIDAK AG and its German subsidiary HEIDAK GmbH, which distribute natural medicines, care products, packaging material, and other products.

Lisa Katharina Haag

Managing Partner at MJ Universe GmbH, Publisher at krautinvest.de

Lisa Haag, an entrepreneur in the German cannabis industry, founded MJ Universe GmbH in Berlin in 2018 as a digital strategy and consulting agency. She advocates especially for the medical use of cannabis, its normalization into the mainstream, and for social justice reform. Haag is active on the board of BvCW e.V. and in the leadership team of the EmpowHer Cannabis Society.

Franz Josef Sima

Horticulture Service Specialist at Fluence

Franz is the 4th generation of a nursery family operating greenhouses since 1890 in southern Austria. Raised in the greenhouses, he developed a natural passion for cannabis in his teenage years. Motivated by the medical benefits and alternatives to conventional pharmaceuticals, Franz transitioned from Austria’s “grey market” to the medical cannabis industry. His experience with thousands of plants in his own clone production provides a stable base for his clients, ensuring efficient production start-ups or improvements in existing operations.

Marc Montandon

Founder & Owner of CarbonActive Products AG

Marc Montandon is regarded as a pioneer in the field of filtration and climate technology for cannabis indoor facilities and has been active in this industry for over 20 years. As the founder and CEO of CarbonActive, he is considered one of the market leaders and trailblazers with groundbreaking approaches. The primary focus of his innovations is on achieving the best possible energy efficiency while keeping the plant at the center.

Martijn Vernnoij

Technical Sales Consultant at Bosman van Zaal

With my cultivation knowledge gained in the past, I advise/help people/clients so that they arrive at the right choices for their future cultivation facility

Mikhail Sagal

President of TSRgrow

For 15 years, Mikhail Sagal has been on the forefront of innovative LED and cultivation technology solutions that maximize consistent quality yields. With a commitment to sustainability and cGMP standards, he has led TSRgrow to be a global leader in solutions that include advanced LED lighting, remote power, master recipes & comprehensive data & analytics.

Adi Rozenfeld

Partner at Herzog Fox & Neeman

Adi provides legal consultation in corporate law and M&A, with expertise in the cannabis sector. She advises companies at all stages of production and supply, handling licenses, compliance, corporate matters, and strategic partnerships. Adi supports local and global clients in corporate transactions and collaborations. She also lectures on cannabis law at various universities in Israel and speaks at industry events. Previously, Adi worked at Ernst & Young, managing employee benefits and tax arrangements.

Borys Danevych [Moderator]

Partner at CMS Cameron McKenna Nabarro Olswang

Borys Danevych, Partner at CMS Ukraine, leads the Life Sciences & Healthcare practices with over 18 years of experience. He advises pharmaceutical, biotech, and medical device companies on regulatory, compliance, IP, and commercial matters. Recognized by Best Lawyers 2022 and Legal 500, he co-chairs the Healthcare Committee of the American Chamber of Commerce and advises the European Business Association in Ukraine. Borys has participated in numerous regulatory working groups and was a member of the Public Control Council of the National Health Service of Ukraine (2020-2023).

Hanna Hlushchenko

CEO & Founder of Ukrainian Cannabis Consulting Group

I have more than 6 years of experience in the medical cannabis space.I coordinated the process of getting a license in Portugal and selling cannabis flowers to Europe. Now I focuses on developing the Ukrainian market by implementing the European experience of regulating the medical cannabis industry.

Leon J. Braun

Managing Director at alephSana

Our society needs holistic therapeutic approaches that harness the power of natural active ingredients. I strive to take one step in the right direction every day to help make this vision a reality.

Lisa Katharina Haag [Moderator]

Managing Partner at MJ Universe GmbH, Publisher at krautinvest.de

Niels Lutzhöft

Partner Bird & Bird LLP

Dr. Niels Lutzhöft LL.M. (Columbia) is an IP partner at Bird & Bird LLP, providing strategic advice and litigation for companies in Life Sciences and Digital Media sectors, focusing on the intersection of IP and sector-specific regulation. He represents food, tobacco, pharmaceutical, and supplement manufacturers in competitive and administrative disputes over product communication, advertising, and claims. His expertise includes advising and litigating in medical cannabis and CBD. He assists cannabis companies entering the German market, in court cases on product and medical advertising law, and in proceedings and negotiations with regulatory authorities.

Nikita Cretu

Co-found & Chief Operations Officer of Lumino

Nikita Cretu, Co-founder and COO of Lumino, a key player in HR consultancy & recruitment for the European Cannabis Industry. With a rich background in cannabis-related consulting across Europe Nikita has leveraged his and the team's passion and expertise to position Lumino at the forefront of building successful teams for the industry's leading medical and recreational companies and brands. From establishing the teams for the first medical clinics in the UK to securing and staffing out significant cultivation licenses throughout Europe and beyond.

Thomas Hauk

Founder of Hauk Consultancy

Thomas Hauk is an entrepreneur and consultant with over 10 years of experience in the Medtech industry. He co-founded a medical cannabis company in 2019 and has been an active member of the BvCW. As an advocate for legalization and an activist with the DHV, he has been involved in the legislative process. He has also worked in the pharmaceutical wholesale industry for medical cannabis.

Vanessa Kulik

Founder of Akademio – Educational Center and Business Solutions

I am a graduate economist and started working in the field of prevention 12 years ago and trained as an addiction counselor. Since then, I have been advising companies, training employees on this topic and carrying out projects at schools and training centers to educate younger people on the topic.

David A. Culver

Senior Vice President & Public Affairs at United States Cannabis Council, Washington, DC USA

David Culver is the SVP of Public Affairs at the US Cannabis Council with over 25 years of experience in global strategies for trade associations and regulated industries like cannabis and alcohol. He previously led global government relations at Canopy Growth and played key roles in USCC and DISCUS, including passing the Craft Beverage Modernization & Tax Reform Act.

Ben Niehaus

Managing Director of SpexAI GmbH

Ben Niehaus, founder of SpexAI GmbH, pioneers controlled environment agriculture (CEA) with over 10 years in digital phenotyping. He led projects like the world's largest agricultural robot. At SpexAI, he revolutionizes cannabis cultivation with AI and spectral imaging, boosting plant health, yield, and sustainability.

Rob Perry

Vice President Business Development of GrowerIQ

Rob has over 20 years of experience in driving operational efficiency. After working with leading financial institutions, he transitioned to the medical cannabis industry in Canada. At GrowerIQ, Rob helped grow the company into one of the largest cannabis software platforms, addressing regulatory, informational, and operational challenges for producers worldwide.

Torsten Schober

Research Associate & PhD Candidate at the University of Hohenheim, Department of Crop Science

Originally trained viticulturist and winemaker with several years of industry experience. Now a research associate in the research group at the University of Hohenheim with a focus on modeling approaches to describe the growth of cannabis in indoor cultivation.

Aleksandra Vujinović

Attorney at Law & Founding Partner at Lito Law Academy GmbH

Aleksandra Vujinovic is an attorney specializing in cannabis law, as well as corporate and commercial law. She advises companies and investors on (inter)national transactions and is a Founding Partner of the Lito Law Academy, where she teaches about the establishment and operation of cannabis clubs.

Jon Robson

CEO of Mamedica Limited

CEO and founder of MAMEDICA®, a clinic and pharmacy for cannabis-based medicines, and CLEARLEAF®, a startup for cannabis-derived products. With 18 years in financial markets, I traded for Credit Suisse, Goldman Sachs, Morgan Stanley, UBS, and Berkshire Hathaway subsidiaries. From 2011-2020, I traded equity derivatives at Sunrise Brokers, boosting revenue before its sale to BGC Partners.

Josh Normanton

Barrister at Trinity Chambers

Josh is a sought-after advocate in high-profile, complex cases, specializing in criminal, regulatory, disciplinary, and financial services law. He handles serious crime cases involving violence, sex, and drugs, and financial crime cases like multi-million-pound frauds. He advises on regulatory issues in transactions, provides strategic advice to individuals, and guides on licensing in novel food and legal cannabis markets. Josh joined Trinity in 2022, practicing on the North-East Circuit.

Nick Kenny

Company Director of Kenny Business Solutions Ltd

Nick is an experienced strategic advisor, specialising in advising large corporations, investment funds and early stage businesses on navigating and entry into evolving highly regulated markets, such as the tobacco, cannabis, nootropics and psychedelic industries.

Robert Jappie [Moderator]

Partner at Fieldfisher LLP

Farida Hussain [Moderator]

International Sales Manager - Europe at Pipp Horticulture

Farida has been in the cannabis industry for 6 years and has learned the intricacies of culture and trends regarding medical cannabis and emerging markets within Europe.

Jillian Reddish

Co-Founder of Global Cannabis Network Collective (GCNC)

Jill Reddish is the co-founder of Project Evolve and the Global Cannabis Network Collective, a private executive network for leaders of multinational cannabis and hemp companies. An award-winning communications strategist, she previously worked with MJBiz to establish MJBizCon as the global leader in industry connectivity.

Kate Holste

Head of International Sales at Boveda

In her 9 years at Boveda, Kate has spent the last 7 years growing Boveda's international business in both cannabis and tobacco. She has achieved a presence in over 115 countries - with no signs of stopping. Also an active member of the EmpowHer Cannabis Society.

Michael Sassano

Founder & interim CEO of SOMAÍ Pharmaceuticals

Michael Sassano is one of the most respected executives in the medicinal cannabis space. He is celebrated in mainstream business and biopharma media as an international authority on developing large-scale cannabis infrastructures worldwide and the most advanced pharmaceutical cannabinoid products.

Michael Steinmetz

Founder & Chief Servant Officer at Flow Kana & Flow Konnect

Flow Kana was the #1 Sungrown flower brand of CA. A pioneer in the Sungrow/regenerative movement raising +$200M and creating the world’s largest cannabis campus for processing and mid supply chain centralized services- Flow Cannabis Institute. Now expanding with products and services to the EU and the larger global market.

Alexander Rieg

Consultant & Owner AR Pharma Consulting

With more than 20 years of experience in healthcare management, I was one of the first entrepreneurs in Germany to set up a wholesale business for medical cannabis in 2017. Since 2020, I’ve been advising pharmaceutical and healthcare companies as an independent consultant on regulatory, sales and market-related topics and have held various management positions.

Alisia Ratliff

Operational Director & Global Business Unit Head KD Phyto GmbH

We serve the German cannabis industry as a cannabinoid ingredient manufacturer, offering services like extraction, distribution, and product development. Alisia Ratliff, a biotech and cannabis executive with 15+ years of experience, specializes in chemistry, project management, and operations. A Fellow of the Royal Society of Chemistry, she is a trusted authority on sustainability and innovation.

Lily Temperton [Moderator]

Partner at Tocar Advisors

Lily is a UK-based international cannabis analyst and advisor. As Partner at Tocar Advisors, she provides strategic guidance to mainstream firms, investors and entrepreneurs, with a particular interest in next-gen products and cannabis consumer culture. She has authored multiple widely referenced industry reports.

Rui Soares

CEO of Paralab Green

Rui Soares is the founder and CEO of Paralab, which has been providing cutting-edge instrumentation solutions for over 30 years. Paralab’s new cannabis-specific division, Paralab Green, offers EU-GMP compliant solutions for all cannabis processing stages. ISO9001:2015 certified, Paralab ensures high-quality standards and customer satisfaction. It holds an EU-GMP lab certification and a recent R&D license for cannabis.

Amber Lengacher

Cannabis Business Attorney at Kight Law Office, PC

Amber D. Lengacher began her cannabis law journey in 2016 while in law school. She worked at Vicente LLP, serving cannabis and hemp clients in licensing, compliance, and corporate governance. In 2020, Amber joined Trulieve Cannabis Corp., aiding in a historic merger. She founded her consulting firm, Purple Circle, in 2022, focusing on equity and accessibility in emerging industries.

Marie Sanchez [Moderator]

Lawyer & Founder Nooa Avocats

Vojtěch Sucharda

Partner at Arrows ETL Global

Vojtech Sucharda specializes in intellectual property law, IT, and trademarks. He represents clients in litigation, arbitration, and insolvency proceedings. As a senior associate at ARROWS International and Head of Legal Practice at ETL Global, he leads an international network providing legal services across Europe. An expert on Czech cannabis regulation, he advises on M&A transactions, lottery law, and the tobacco industry. He holds an ILEC certificate from Cambridge University and studied European and international law at the Hague Hoge School.

Maren Krings

Photographer, Climate Impact Storyteller

Maren Krings is a Climate Impact Storyteller leveraging her expertise in photography, content writing, and keynote speaking to highlight the potential of hemp for climate resilience and social justice.

Chris Murray

Director of FoxNRTH Inc

Chris Murray ist Gründer und Leiter der Beratungsgruppe FoxNRTH Inc. Er gründete das Unternehmen im Jahr 2020, nachdem er die vorangegangenen sieben Jahre damit verbracht hatte, Canopy Growth Corp aufzubauen und Teil des Gründungsteams zu sein. Im Laufe der letzten zehn Jahre hat Chris in oder mit Unternehmen in allen wichtigen aktiven Cannabis-Regionen der Welt gearbeitet.

Deepak Anand [Moderator]

Principal at ASDA Consultancy Services

Deepak Anand is a distinguished thought leader and expert in the global cannabis industry. He engages with senior government officials, policymakers, investors, and leading producers worldwide. As founder of a boutique consulting firm, he provides tailored services to international governments, regulators, and major entities in CPG, beverages, alcohol, pharmaceuticals, and tobacco sectors. Anand holds influential positions on industry boards and pharmaceutical associations across Canada, the U.S., and Europe. He has served as the founder and executive director of the Canadian National Medical Marijuana Association and held leadership roles, including CEO and Director, in various cannabis companies. With an MBA from Vancouver Island University, Anand actively participates in boards of not-for-profit organizations, advocacy groups, and patient initiatives, enhancing his global impact as a social media influencer.

Omar Khan

Chief Communications and Public Affairs Officer at High Tide Inc.

Omar is a seasoned cannabis industry expert with over 20 years of experience in political and communications strategy. He previously led the National Cannabis Sector at a global communications firm, working with producers and retailers to influence policy. Omar has served as Chief of Staff to multiple Ontario Ministers.

William Muecke

Co-founder & Managing Member of Artemis Growth Partners

Will Muecke is a co-founder and managing member of Artemis Growth Partners, an ESG-focused private equity firm investing exclusively in the global cannabis industry. Artemis oversees $400M in assets across the cannabis value chain. Will has a background in impact investing and healthcare banking and is now CIO of Artemis, based in London.

Bijan Christoph Hezarkhani [Moderator]

Founder & Consultant of BCH Consulting

Bijan has worked for Canopy Growth and Khiron Life Sciences in the past and now consults cannabis businesses on market entry and commercial strategy. As a certified pharmaceutical consultant he has had countless interactions with physicians, pharmacists and patients and now focuses on leveraging education and data analytics to increase access to cannabinoid medicines. His company BCH Consulting works across a number of industries including Pharma, Cannabis, Health Tech, FMCG and more. Specialising in business scaling and international expansion, BCH Consulting seeks to improve commercial efficiency by achieving harmony between sales, marketing and CRM/data analytics strategies.

Marcel Riggs

Director Business Development Europe at Aurora Europe

Based in Germany, Marcel Riggs, is the Business Development Lead for Aurora in Europe. As a specialist in consumer goods sales, he is growing the markets outside of Germany for one of the most profitable cannabis companies in the world.

Philipp Goebel

Managing Director of Demecan

The Doctor of Business Administration in Supply Chain Management brings extensive marketing and sales experience in the pharmaceutical sector to the Saxon cannabis specialist. Previously leading Merck's Neurology & Immunology Business Unit and with oncology experience, he managed Bertelsmann's German After Sales for telecom customers. At DEMECAN, he will apply his expertise in advanced supply chain management and digitalization.

Šárka Betke

Commercial Director at SensiQure

Šárka Betke, is an entrepreneur and commercial strategist who led sales teams at various tech firms before founding a wine distribution business in 2020. Currently as a Commercial Director at SensiQure, she drives the company's strategy and growth in the medical cannabis sector.

Sascha Mielcarek

CEO of Canify AG

25 years of leadership experience in international healthcare industry with far-reaching operational expertise and a strong track record in the cannabis industry, previously leading Tilray to market leadership in Europe. Within a year, developed Canify into a profitable cannabis company, entering the Top10 in Germany.

Thomas Ahlberg

Director of Strategy at Cantourage Group SE

After various cannabis cultivation site design, construction and ramp-up projects in North America, Thomas was head of planning and construction of the largest German cannabis GMP production facility. He developed multiple plant-touching US and German cannabis companies in pivotal management roles.

Jason Moscovici [Moderator]

Founder & President of Provisions Legal Services Inc.

Shane Pennington

Partner at Porter Wright Morris & Arthur LLP

Shane, a partner in the Litigation Department, advises on federal regulatory issues in energy, pharmaceuticals, controlled substances, aviation, and agriculture. A former federal law clerk, he is recognized as a “Rising Star” in appellate law. Shane has argued landmark cases and litigates involving the Administrative Procedure Act, Controlled Substances Act, and FDA regulations. He collaborates with regulators for innovative solutions and publishes extensively on administrative law and drug policy.

Spiros Malandrakis

Head of Research – Alcoholic drinks and Cannabis at Euromonitor International

Spiros has been a pioneering, authoritative and irreverent voice within the Alcohol and Cannabis industries for the past 2 decades , providing insights for key players and the person of contact for numerous leading media publications

Bill Purves

Chief Commercial Officer at Brains Bioceutical Corp

Experienced commercial executive with over 25 years in global biopharmaceutical and medical cannabis industries. Senior roles at GSK, including CFO of Sub-Saharan Africa and Executive Director of Business Development (International Region). Co-founder of a pharma development company.

Ilias Manolopoulos

Managing Director UK & Germany of Therakann Pharmaceuticals

Mr Ilias Manolopoulos has a 10-year experience in the retail, mechanical and engineering industry. The last 5 years he was acting as an Operations Manager with a focus in Purchasing, Quality, Production Planning and Systems. He also has additional skills in budgeting, business planning and cash flow forecasting.

Nadine Herwig

Head of Grünhorn Academy

Dr. rer. nat. Nadine Herwig is a biochemist and the head of the Grünhorn Academy. With over a decade of experience, she has held roles at the Cannabis Group Grünhorn and Drug Approval Specialist at Abanta Pharma GmbH. Previously, she taught biology and chemistry and worked as a Research Scientist at Helmholtz-Zentrum Dresden-Rossendorf. An esteemed researcher in terpenes, Dr. Herwig recently published a paper on the reclassification of cannabis.

Nicole Besse

Commercial Director at Tilray Deutschland GmbH

Nicole Besse is the Commercial Director Germany at Tilray, a leading global cannabis company. With extensive pharmaceutical experience, she specializes in expanding brands in emerging markets. At Tilray, she drives commercial initiatives in Germany, a key medical cannabis market. As a speaker at Mary Jane 2024, Nicole will share insights on the German medical cannabis market and Tilray's role in shaping its future.

Aron Byrne-Carter

Director at NGP Trends

Aron is an NGP expert and through his company NGP Trends provides businesses with technical insights and product development support in the vape, heated tobacco, and nicotine sectors. Through monthly reports, consulting, and workshops, he helps clients take concepts to volume manufacturing, unlocking consumer value from technology benefits.

Georgia Glick [Moderator]

Partner at Tocar Strategic Advisors

Georgia specialises in commercial strategy and investor relations. As partner at Tocar Strategic Advisors, Georgia plays a crucial role in conducting due diligence on potential investments and acquisitions for Tocar’s clients. Georgia’s considerable knowledge of the cannabis sector, spanning medical, CBD and recreational cannabis, has led her to establish a strong global network. Leveraging these valuable connections, she excels at forging strategic partnerships and facilitating fruitful collaborations for her clients. Alongside her role at Tocar, Georgia also acts as a portfolio manager for an international family office.

Hari Guliani

Co-founder of GSQ Trading

Hari is co-founder of GSQ, a wholesaler of high quality hardware in the U.K. and beyond. GSQ is the exclusive U.K. authorised distributor of ACTIVE (formerly AVD). Previously, Hari introduced the first U.K. manufactured THC vape for the medical market at Columbia Care.

Tim Matthews

CEO of Curb Living

Tim Matthews, CEO of CURB, is a visionary leader with 30 years of innovative expertise. Under his guidance, CURB is pioneering next-generation products and leveraging cannabis industry insights to redefine reduced-risk vaping technology.

Giacomo Bulleri

Lawyer & Advisor at Studio Legale Bulleri

Giacomo Bulleri is a civil lawyer specializing in corporate, commercial, and real estate law. He is a delegate for real estate sales at the Court of Livorno and an arbitrator at the Maremma and Tyrrhenian Chamber of Commerce. An expert in industrial and therapeutic cannabis, he helped draft Law 242/2016 and consults for Federcanapa and other companies. He serves on the EIHA advisory board and has spoken at numerous cannabis regulation conferences.

Guillermo Fernández Navarro

CEO of Soriano Fernandez Abogado, SLP

Founder and CEO of S&F Abogados in Madrid, Guillermo specializes in the cannabis industry. For over 10 years, he has defended cannabis growers, producers, clubs, grow shops, and seed banks. He advises on CBD and THC sales in Spain and Europe and assists in obtaining licenses for medical cannabis and extraction. Guillermo also advocates for cannabis use, collaborating with national organizations.

Ohad Kiperstok [Moderator]

Partner at Angel, Kiperstok y Asociados

He is a lawyer and founding partner of the firm, specializing in commercial, banking, civil, and criminal litigation in the Accusatory Criminal System. He focuses on commercial law, corporate law, asset protection, Private Interest Foundations, and Public Limited Companies. He holds a Bachelor's degree in Law and Political Sciences from ISAE University and is an active member of the National Bar Association.

Ricardo Omar Almanza

CEO & International Business Developer at 420 Latam Anutea

Since 2018, I've been an entrepreneur in the cannabis field in Mexico, US, and Colombia. I have degrees in International Trade (UVA) and Law (ULA), and have completed a Cannabis Management course (KPU) Vancouver, indigenous advisor in Mexico and wrote "Hablemos de Marihuana." (let's talk about Marihuana)

Susanne Pech

Counsel | Attorney at CMS Hasche Sigle

Life science lawyer Susanne Pech advises pharmaceutical, medical device, and consumer goods companies on unfair competition, advertising (Heilmittelwerbegesetz), product liability, and medical law. She represents clients in court and handles regulatory issues related to medical/recreational cannabis and CBD products.

Armin Prasch

CEO of Trias Pharma GmbH, Board Member of BvCW

Having more than 25 years of experience in the development of pharmaceutical products, Dr. Armin Prasch is committed to securing and developing the potential of cannabis-based medicinal products for medical applications for the benefit of patients. He is a founding and board member of the BvCW, responsible for the ‘Medicinal Cannabis working-group´ and a member of the DPhG's ‘Medicinal Cannabis’ expert group. Armin Prasch is CEO of Trias Pharma GmbH.

Carsten Elfering

Official cannabis patient since 2009, ACM certified consultant for cannabis-based medications

Carsten Elfering is an official BfArM-approved cannabis patient since 2009, an ACM-certified consultant for cannabis-based medications, and a passionate gardener. From 2005 to 2021, he served as a board member of the Association for Cannabis as Medicine (ACM). In 2006, he co-founded the Self-Help Network Cannabis Medicine (SCM), Germany's largest and oldest cannabis patient association, and served as the patient liaison for ACM/SCM.

Thorsten Tuschy

Pharmacist at Apotheke LUX 99

Dr. Thorsten Tuschy was licensed as a pharmacist in 2013 and completed his doctorate at the Institute of Pharmacology at the University Hospital Cologne in 2016. He has been working in the cannabis department of Apotheke LUX 99 in Hürth since 2020, where he is responsible for the medical-scientific department and for internal and external training.

Alfredo Pascual

Director of Investment Research at Seed Innovations Ltd (LON:SEED)

Chief Commercial Officer at Brains Bioceutical Corp

VIEW Speaker

Ongoing Events: 1

All Events: 1

No item found!

Hôtels CB Expo Dortmund, du 19 au 21 septembre 2024

Nous recommandons les hôtels suivants:

Nous vous recommandons de réserver votre hôtel dès que possible, sinon il sera très difficile de trouver un hôtel disponible à Dortmund.

Best Western Hotel Dortmund Airport
hambre à partir de EUR 252.-
Les chambres peuvent être réservées par e-mail (info.dor51@gchhotelgroup.com), ainsi que par téléphone +49 (0) 231 989890.

H+ Hotel Bochum
Chambre à partir de EUR 155.-
Réservations: Téléphone: 0234-92566 511
Email: ReservierungBO@h-hotels.com

Hotel Unique Dortmund
Chambre à partir de EUR 222.-
Les réservations peuvent être effectuées par écrit directement à l’hôtel à l’adresse reservierung@hdhotels.de, par téléphone au 0049 231 -560 500 ou via le site web de l’hôtel.

Ringhotel Drees
Chambre à partir de EUR 160.-
Réservation par téléphone au +49 (0231) 1299 0 ou par e-mail drees@riepe.com

Hampton by Hilton Dortmund Phoenix See
Chambre à partir de EUR 269.-
Les réservations peuvent être effectuées par courrier électronique à l’adresse suivante: reservation@hamptondortmund.de

Moxy Dortmund City
Chambre à partir de EUR 359.-
Réservation: ici